In this section of the General Tradeshow News Site, you'll find event-related news releases from PR Newswire. The releases are listed in chronological order and are archived by month and year.
-First Investigational Therapy in a Pivotal Trial to Address Unmet Need for Patients with Advanced Urothelial Cancer After Treatment with Platinum Chemotherapy and a PD-1 or PD-L1 Inhibitor-
System Creates New Business Opportunities for Advisors by Enabling Flexible Delivery of Comprehensive Financial Planning to Clients Across One-Time, Periodically Recurring or Ongoing Engagement Structures
Teramind upgrades its market leading employee monitoring, user & entity behavior analytics (UEBA) and data loss prevention (DLP) platform with privacy-centric enhancements, debuts for UK, EU companies at Infosecurity Europe
Updated Phase 1 Data of Investigational AMG 420 in Relapsed and/or Refractory Multiple Myeloma Highlighted in Oral Presentation and Accepted for Best of ASCO®
- First-in-human results presented for DS-1062, an investigational TROP2 targeting ADC, in patients with advanced NSCLC where no standard treatment is available
- Lurbinectedin (PharmaMar) achieved the primary endpoint of Overall Response Rate (ORR) in the Phase II trial and has been shown to be active as a single agent in the second line treatment of small cell lung cancer.
- Statistically significant biologic anti-tumor activity demonstrated as measured by a reduction in Ki67 in patients treated with ME-344 compared to an increase in patients receiving placebo -